
5.58 BATS BZX Real-Time Price As of 1:04pm ET | ![]() Today’s Change | 3.56 Today|||52-Week Range 24.75 | +9.20% Year-to-Date |
The 5 analysts offering 12-month price forecasts for Checkpoint Therapeutics Inc have a median target of 41.00, with a high estimate of 96.00 and a low estimate of 15.00. The median estimate represents a +634.77% increase from the last price of 5.58.
The current consensus among 5 polled investment analysts is to Buy stock in Checkpoint Therapeutics Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.